{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T02:24:03Z","timestamp":1777602243751,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T00:00:00Z","timestamp":1536192000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s00066-018-1365-4","type":"journal-article","created":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T13:26:11Z","timestamp":1536240371000},"page":"103-112","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Comparison of relative and absolute rectal dose\u2013volume parameters and clinical correlation with acute and late radiation proctitis in prostate cancer patients","Vergleich von relativen und absoluten rektalen Dosis-Volumen-Parametern und klinische Korrelation mit akuter und sp\u00e4ter radiogener Proktitis bei Prostatakarzinompatienten"],"prefix":"10.1007","volume":"195","author":[{"given":"Roman","family":"Paleny","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Bremer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Walacides","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silke","family":"Mainwaring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0721-5683","authenticated-orcid":false,"given":"Christoph","family":"Henkenberens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,9,6]]},"reference":[{"key":"1365_CR1","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.ijrobp.2016.01.031","volume":"95","author":"RC Wortel","year":"2016","unstructured":"Wortel RC, Incrocci L, Pos FJ, van der Heide UA, Lebesque JV, Aluwini S et al (2016) Late side effects after image guided intensity modulated radiation therapy compared to 3D-Conformal radiation therapy for prostate cancer: results from 2 prospective cohorts. Int J Radiat Oncol Biol Phys 95:680\u2013689","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1365_CR2","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S1470-2045(15)70045-8","volume":"16","author":"A Zapatero","year":"2015","unstructured":"Zapatero A, Guerrero A, Maldonado X, Alvarez A, Gonzalez San Segundo C, Cabeza Rodriguez MA (2015) High-dose radiotherapy with short-term or long-term androgen deprivation in localised prostate cancer (DART01\/05 GICOR): a\u00a0randomised, controlled, phase 3 trial. Lancet Oncol 16:320\u2013327","journal-title":"Lancet Oncol"},{"issue":"1","key":"1365_CR3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s00066-017-1215-9","volume":"194","author":"C Waldstein","year":"2017","unstructured":"Waldstein C, D\u00f6rr W, P\u00f6tter R, Widder J, Goldner G (2017) Postoperative radiotherapy for prostate cancer: morbidity of local-only or local-plus-pelvic radiotherapy. Strahlenther Onkol 194(1):23\u201330. \n                    https:\/\/doi.org\/10.1007\/s00066-017-1215-9","journal-title":"Strahlenther Onkol"},{"key":"1365_CR4","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.eururo.2014.03.011","volume":"66","author":"T Wiegel","year":"2014","unstructured":"Wiegel T, Bartkowiak D, Bottke D, Bronner C, Steiner U, Siegmann A et al (2014) Adjuvant radiotherapy versus wait-and-see after radical prostatectomy: 10-year follow-up of the ARO 96-02\/UO AP 09\/95 trial. Eur Urol 66:243\u2013250","journal-title":"Eur Urol"},{"key":"1365_CR5","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1007\/s00066-017-1140-y","volume":"193","author":"L Bud\u00e4us","year":"2017","unstructured":"Bud\u00e4us L, Schiffmann J, Graefen M, Huland H, Tennstedt P, Siegmann A et\u00a0al (2017) Defining biochemical recurrence after radical prostatectomy and timing of early salvage radiotherapy: informing the debate. Strahlenther Onkol 193:692\u2013699","journal-title":"Strahlenther Onkol"},{"issue":"4","key":"1365_CR6","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00066-017-1247-1","volume":"194","author":"G Lohm","year":"2017","unstructured":"Lohm G, Neumann K, Budach V, Wiegel T, Hoecht T, Gollrad J (2017) Salvage radiotherapy in prostate cancer patients with biochemical relapse after radical prostatectomy: prolongation of prostate-specific antigen doubling time in patients with subsequent biochemical progression. Strahlenther Onkol 194(4):325\u2013332. \n                    https:\/\/doi.org\/10.1007\/s00066-017-1247-1","journal-title":"Strahlenther Onkol"},{"key":"1365_CR7","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.ijrobp.2009.02.025","volume":"76","author":"SL Gulliford","year":"2010","unstructured":"Gulliford SL, Foo K, Morgan RC, Aird EG, Bidmead AM, Critchley H et al (2010) Dose-volume constraints to reduce rectal side effects from prostate radiotherapy: evidence from MRC RT01 Trial ISRCTN 47772397. Int J Radiat Oncol Biol Phys 76:747\u2013754","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1365_CR8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ijrobp.2009.07.1754","volume":"76","author":"LB Marks","year":"2010","unstructured":"Marks LB, Yorke ED, Jackson A, Ten Haken RK, Constine LS, Eisbruch A et\u00a0al (2010) Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys 76:10\u201319","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3 Suppl","key":"1365_CR9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ijrobp.2009.03.078","volume":"76","author":"JM Michalski","year":"2010","unstructured":"Michalski JM, Gay H, Jackson A, Tucker SL, Deasy JO (2010) Radiation dose-volume effects in radiation-induced rectal injury. Int J Radiat Oncol Biol Phys 76(3 Suppl):123\u2013129","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1365_CR10","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1080\/0284186X.2017.1370130","volume":"56","author":"O Casares-Magaz","year":"2017","unstructured":"Casares-Magaz O, Muren LP, Moiseenko V, Petersen SE, Pettersson NJ, H\u00f8yer M et al (2017) Spatial rectal dose\/volume metrics predict patient-reported gastro-intestinal symptoms after radiotherapy for prostate cancer. Acta Oncol 56:1507\u20131513","journal-title":"Acta Oncol"},{"key":"1365_CR11","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/00130404-200201000-00011","volume":"8","author":"PA Kupelian","year":"2002","unstructured":"Kupelian PA, Reddy CA, Carlson TP, Wiloughby TR (2002) Dose\/volume relationship of late rectal bleeding after external beam radiotherapy for localized prostate cancer: absolute or relative rectal volume? Cancer\u00a0J 8:62\u201366","journal-title":"Cancer J"},{"key":"1365_CR12","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1001\/jama.280.11.969","volume":"280","author":"AV D\u2019Amico","year":"1998","unstructured":"D\u2019Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA et\u00a0al (1998) Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280:969\u2013974","journal-title":"JAMA"},{"key":"1365_CR13","volume-title":"Common terminology criteria for adverse events v4.0","author":"National Cancer Institute","year":"2010","unstructured":"National Cancer Institute (2010) Common terminology criteria for adverse events v4.0. \n                    https:\/\/evs.nci.nih.gov\/ftp1\/CTCAE\/CTCAE_4.03_2010-06-14_QuickReference_8.5x11.pdf\n                    \n                  . Accessed 22 Dec 2017"},{"key":"1365_CR14","doi-asserted-by":"crossref","unstructured":"LENT SOMA scales for all anatomic sites. (1995) Int J Radiat Oncol Biol Phys 31:1049\u20131092.","DOI":"10.1016\/0360-3016(95)90159-0"},{"key":"1365_CR15","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/S0360-3016(03)00665-5","volume":"57","author":"C Fiorino","year":"2003","unstructured":"Fiorino C, Sanguineti G, Cozzarini C, Foppiano F, Piazzolla A, Menegotti L et al (2003) Rectal dose-volume constraints in high-dose radiotherapy of localized prostate cancer. Int J Radiat Oncol Biol Phys 57:953\u2013962","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1365_CR16","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1016\/j.ijrobp.2007.07.2354","volume":"70","author":"C Fiorino","year":"2008","unstructured":"Fiorino C, Fellin G, Rancati T, Vavassori V, Bianchi VC, Borca VC, Girelli G et al (2008) Clinical and dosimetric predictors of late rectal syndrome after 3D-CRT for localized prostate cancer: preliminary results of a\u00a0multicenter prospective study. Int J Radiat Oncol Biol Phys 70:1130\u20131137","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1365_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0167-8140(02)00147-0","volume":"64","author":"C Fiorino","year":"2002","unstructured":"Fiorino C, Cozzarini C, Vavassori V, Sanguineti G, Bianchi C, Cattaneo GM et\u00a0al (2002) Relationships between DVHs and late rectal bleeding after radiotherapy for prostate cancer: analysis of a\u00a0large group of patients pooled from three institutions. Radiother Oncol 64:1\u201312","journal-title":"Radiother Oncol"},{"key":"1365_CR18","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1093\/jrr\/rru080","volume":"56","author":"M Someya","year":"2015","unstructured":"Someya M, Hori M, Tatoeka K, Nakata K, Takagi M, Saito M et al (2015) Results and DVH analysis of late rectal bleeding in patients treated with 3D-CRT or IMRT for localized prostate cancer. J\u00a0Radiat Res 56:122\u2013127","journal-title":"J Radiat Res"},{"key":"1365_CR19","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s13014-016-0721-8","volume":"11","author":"C Mirjolet","year":"2016","unstructured":"Mirjolet C, Walker PM, Gauthier M, Dalban C, Naudy S, Mazoyer F et al (2016) Absolute volume of the rectum and AUC from rectal DVH between 25 and 50\u202fGy predict acute gastrointestinal toxicity with IG-IMRT in prostate cancer. Radiat Oncol 11:145","journal-title":"Radiat Oncol"},{"key":"1365_CR20","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0167-8140(02)00185-8","volume":"64","author":"JJ Nuyttens","year":"2002","unstructured":"Nuyttens JJ, Milito S, Rust PF, Turrisi AT 3rd (2002) Dose-volume relationship for acute side effects during high dose conformal radiotherapy for prostate cancer. Radiother Oncol 64:209\u2013214","journal-title":"Radiother Oncol"},{"key":"1365_CR21","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1016\/S0360-3016(02)03742-2","volume":"54","author":"EH Huang","year":"2002","unstructured":"Huang EH, Pollak A, Levy L, Starkschall G, Dong L, Rosen I et al (2002) Late rectal toxicity: dose-volume effects of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 54:1314\u20131321","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1365_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/1748-717X-9-129","author":"AM McDonald","year":"2014","unstructured":"McDonald AM, Baker CB, Popple RA, Shekar K, Yang ES, Jacob R et al (2014) Different rectal toxicity tolerance with and without simultaneous conventionally-fractionated pelvic lymph node treatment in patients receiving hypofractionated prostate radiotherapy. Radiat Oncol. \n                    https:\/\/doi.org\/10.1186\/1748-717X-9-129","journal-title":"Radiat Oncol"},{"key":"1365_CR23","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s00066-013-0450-y","volume":"190","author":"M Guckenberger","year":"2014","unstructured":"Guckenberger M, Andratschke N, Alheit N, Holy R, Moustakis C, Nestle U et al (2014) Definition of stereotactic body radiotherapy: principles and practice for the treatment of stage I non-small cell lung cancer. Strahlenther Onkol 190:26\u201333","journal-title":"Strahlenther Onkol"},{"key":"1365_CR24","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00066-014-0648-7","volume":"190","author":"M Kocher","year":"2014","unstructured":"Kocher M, Wittig A, Piroth MD, Treuer H, Seegenschmiedt H, Ruge M et\u00a0al (2014) Stereotactic radiosurgery for treatment of brain metastases. A report of the DEGRO Working Group on Stereotactic Radiotherapy. Strahlenther Onkol 190:521\u2013531","journal-title":"Strahlenther Onkol"},{"key":"1365_CR25","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/S0090-4295(00)00890-6","volume":"57","author":"HK Shu","year":"2001","unstructured":"Shu HK, Lee TT, Vigneauly E, Xia P, Pickett B, Phillips TL et al (2001) Toxicity following high-dose three-dimensional conformal and intensity-modulated radiation therapy for clinically localized prostate cancer. Urology 57:102\u2013107","journal-title":"Urology"},{"key":"1365_CR26","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ijrobp.2007.12.045","volume":"72","author":"LW Chan","year":"2008","unstructured":"Chan LW, Xia P, Gottschalk AR, Akazawa M, Scala M, Picket B et\u00a0al (2008) Proposed rectal dose constraints for patients undergoing definitive whole pelvic radiotherapy for clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 72:69\u201377","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1365_CR27","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.ijrobp.2007.11.044","volume":"70","author":"MJ Zelefsky","year":"2008","unstructured":"Zelefsky MJ, Levin EJ, Hunt M, Yamada Y, Shippy AM, Jackson A et al (2008) Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 70:1124\u20131129","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1365_CR28","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.ijrobp.2014.12.017","volume":"91","author":"RC Wortel","year":"2015","unstructured":"Wortel RC, Incrocci L, Pos FJ, Lebesque JV, Witte MG, van der Heide UA et al (2015) Acute toxicity after image-guided intensity modulated radiation therapy compared to 3D conformal radiation therapy in prostate cancer patients. Int J Radiat Oncol Biol Phys 91:737\u2013744","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1365_CR29","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1016\/j.ijrobp.2004.07.712","volume":"60","author":"SL Tucker","year":"2004","unstructured":"Tucker SL, Dong L, Cheung R, Johnson J, Mohan R, Huang EH et al (2004) Comparison of rectal dose-wall histogram versus dose-volume histogram for modeling the incidence of late rectal bleeding after radiotherapy. Int J Radiat Oncol Biol Phys 60:1589\u20131601","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1365_CR30","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s00066-006-1566-0","volume":"182","author":"M Guckenberger","year":"2006","unstructured":"Guckenberger M, Pohl F, Baier K, Meyer J, Koebl O, Flentje M et\u00a0al (2006) Influence of rectum delineation (rectal volume vs. rectal wall) on IMRT treatment planning of the prostate. Strahlenther Onkol 182:721\u2013726","journal-title":"Strahlenther Onkol"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-018-1365-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-018-1365-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-018-1365-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T12:36:40Z","timestamp":1567773400000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-018-1365-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,6]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["1365"],"URL":"https:\/\/doi.org\/10.1007\/s00066-018-1365-4","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,6]]},"assertion":[{"value":"8 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.\u00a0Paleny, M.\u00a0Bremer, D.\u00a0Walacides, S.\u00a0Mainwaring, K.\u00a0Weber and C.\u00a0Henkenberens declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}